- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02230280
My Stroke Team (MYST): Stroke App Pilot Study
Strengthening Community-Based Stroke Care: A Pilot Study of a Community Navigation and Rehabilitation Intervention That Includes a Mobile Health Solution
Study Overview
Status
Conditions
Detailed Description
Research Questions:
- What is the feasibility and acceptability of the MYST app within the context of a 6-month community navigation and rehabilitation intervention from the perspectives of health care providers, clients, and family caregivers?
- What are the MYST app usage patterns by various subgroups of end-users (e.g., clients, health-care providers, age groups of HCPs, stroke survivors and family caregivers)?
- What is the effect of the intervention on stroke survivors' health-related quality of life, community re-integration, physical functioning, depression, anxiety, self-efficacy, and costs of use of health services, from a societal perspective?
- What is the effect of the intervention on family caregivers' health-related quality of life, caregiver strain, depression, anxiety, and costs of use of health services from a societal perspective?
- What is the effect of the intervention on HCP outcomes (interprofessional collaboration)?
Methods:
Due to the complexity of evaluating health services interventions, a mixed methods design will be used to evaluate the multi-component intervention. A pragmatic pre-test post-test single site study design will be used to evaluate the intervention. By pragmatic, the investigators mean the intervention will be implemented under real-world conditions, including reliance on existing staff at the participating site. Assessments will be made at baseline (pre-test) and immediately following the six-month intervention period (post-test). Descriptive qualitative methods will be used to explore the feasibility and acceptability of the intervention.
Outcomes will be assessed at baseline and 6 months. Summary descriptive measures will be reported for all variables.
Expected Outcomes:
It is expected that stroke survivors with multiple chronic conditions, their family caregivers and healthcare providers will find the MYST app acceptable and feasible.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4L8
- Hamilton Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants are newly referred for outpatient rehabilitation with a confirmed diagnosis of stroke (first ever or recurrent) within the past 12 months, and are not planning to move away from the community in the next 6 months. Participants have at least 2 predetermined comorbid conditions, and must have the capacity to provide informed consent, either independently or by substitute decision maker.
Exclusion Criteria:
- Participants will be excluded if they are unable to read and understand English and do not have access to a translator.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: The intervention cohort.
A community transition and rehabilitation intervention that includes a mobile health solution
|
Participants will be offered regular in-home visits over the 6-month study period in addition to usual outpatient rehabilitation services.
The health care providers will have access to a mobile health application (MYST) to share real-time information and access community resources and best practice guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in health-related quality of life (HRQoL) for both stroke survivors and caregivers as measured by the SF-12
Time Frame: Baseline and the end of the intervention (6 months from baseline)
|
The Short-Form 12(SF-12) Health Survey will be administered to stroke survivors and caregivers to measure health-related quality of life
|
Baseline and the end of the intervention (6 months from baseline)
|
|
Feasibility of the mobile application as part of the intervention.
Time Frame: At the end of the intervention (6 months)
|
Participants' perspectives on the feasibility of the mobile application will be assessed qualitatively through focus groups (HCPs) and interviews (stroke survivors and family caregivers).
|
At the end of the intervention (6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the degree of physical functioning related to stroke.
Time Frame: Baseline and the end of the intervention (6 months from baseline)
|
The Stroke Impact Scale (SIS)-16 will be administered to stroke survivors at baseline and 6 months, to assess physical functioning related to stroke
|
Baseline and the end of the intervention (6 months from baseline)
|
|
Change in the prevalence and severity of depression symptoms in stroke survivors and family caregivers.
Time Frame: Baseline and the end of the intervention (6 months from baseline)
|
The Centre for Epidemiological Studies Depression Scale (CES-D-10) will be used to assess the prevalence and the severity of depression symptoms.
|
Baseline and the end of the intervention (6 months from baseline)
|
|
Change in the degree of strain of family caregiver.
Time Frame: Baseline and the end of the intervention (6months from baseline)
|
The Modified Caregiver Strain Index(CSI) will be administered to every stroke survivor's family caregiver at baseline and at 6 months to assess change in burden associated with caregiving
|
Baseline and the end of the intervention (6months from baseline)
|
|
Change in prevalence and severity of anxiety.
Time Frame: Baseline and end of intervention (6 months from baseline)
|
The Generalized Anxiety Disorder Screener-7 (GAD-7) scale will be used to assess changes in the degree of anxiety of stroke survivors at baseline and 6 months from baseline.
|
Baseline and end of intervention (6 months from baseline)
|
|
Change in the self efficacy of stroke survivors.
Time Frame: Baseline and end of the intervention (6 months from baseline)
|
The Stanford's 6-item Self-Efficacy for Managing Chronic Disease Scale (SE-MCD) will be administered to stroke survivors to assess changes in self efficacy at baseline and end of the study.
|
Baseline and end of the intervention (6 months from baseline)
|
|
Change in the community integration of stroke patients.
Time Frame: Baseline and end of the intervention (6 months from baseline)
|
The Reintegration to Normal Living Index (RNLI) will be administered to stroke survivors to assess degree of community reintegration post-stroke.
|
Baseline and end of the intervention (6 months from baseline)
|
|
Change in the costs of use of health services by stroke survivors and family caregivers
Time Frame: Baseline and end of intervention (6 months from baseline)
|
The costs of use of all types of health services from baseline to six months will be determined using the Health and Social Services Utilization Inventory (HSSUI).
|
Baseline and end of intervention (6 months from baseline)
|
|
Change in team functioning.
Time Frame: At three months into the intervention study and upon completion of the study (16 months)
|
The Collaborative Practice Assessment Tool will be administered to home care providers to assess changes in team functioning.
|
At three months into the intervention study and upon completion of the study (16 months)
|
|
Change in level of integration between home care providers.
Time Frame: At three months into the intervention study and upon completion of the study (16 months)
|
The Team Climate Inventory will be administered to home care providers to assess changes in their level of integration.
|
At three months into the intervention study and upon completion of the study (16 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maureen Markle-Reid, RN, PhD, McMaster University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STPILOT-134162
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Strengthening Community-Based Stroke Care: A Pilot Study of a Community Navigation and Rehabilitation Intervention that Includes a Mobile Health Solution
-
Duke Kunshan UniversityDhulikhel HospitalNot yet recruiting
-
Yating LiuCompletedHypoglycemia | Type 2 Diabetes Mellitus | Health EducationChina
-
King Faisal Specialist Hospital & Research CenterNot yet recruitingRotator Cuff TearSaudi Arabia
-
Centre for Infectious Disease Research in ZambiaRecruitingHIV Viremia | HIV -1 InfectionZambia
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Lymphoma | Multiple Myeloma | Hematopoietic and Lymphoid System Neoplasm | Chronic LeukemiaUnited States